 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
3hsm
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Signaling protein
|
 |
|
Title:
|
 |
Crystal structure of distal n-terminal beta-trefoil domain of ryanodine receptor type 1
|
|
Structure:
|
 |
Ryanodine receptor 1. Chain: a, b. Fragment: sequence database residues 1-210. Synonym: ryr-1, ryr1, skeletal muscle-type ryanodine receptor, skeletal muscle calcium release channel. Engineered: yes
|
|
Source:
|
 |
Oryctolagus cuniculus. Rabbit. Organism_taxid: 9986. Gene: ryr1. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
2.50Å
|
R-factor:
|
0.229
|
R-free:
|
0.276
|
|
|
Authors:
|
 |
F.J.Amador,S.Liu,N.Ishiyama,M.J.Plevin,A.Wilson, D.H.Maclennan,M.Ikura
|
Key ref:
|
 |
F.J.Amador
et al.
(2009).
Crystal structure of type I ryanodine receptor amino-terminal beta-trefoil domain reveals a disease-associated mutation "hot spot" loop.
Proc Natl Acad Sci U S A,
106,
11040-11044.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
10-Jun-09
|
Release date:
|
28-Jul-09
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
membrane
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
106:11040-11044
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of type I ryanodine receptor amino-terminal beta-trefoil domain reveals a disease-associated mutation "hot spot" loop.
|
|
F.J.Amador,
S.Liu,
N.Ishiyama,
M.J.Plevin,
A.Wilson,
D.H.MacLennan,
M.Ikura.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Muscle contraction and relaxation is regulated by transient elevations of
myoplasmic Ca(2+). Ca(2+) is released from stores in the lumen of the
sarco(endo)plasmic reticulum (SER) to initiate formation of the Ca(2+) transient
by activation of a class of Ca(2+) release channels referred to as ryanodine
receptors (RyRs) and is pumped back into the SER lumen by Ca(2+)-ATPases
(SERCAs) to terminate the Ca(2+) transient. Mutations in the type 1 ryanodine
receptor gene, RYR1, are associated with 2 skeletal muscle disorders, malignant
hyperthermia (MH), and central core disease (CCD). The evaluation of proposed
mechanisms by which RyR1 mutations cause MH and CCD is hindered by the lack of
high-resolution structural information. Here, we report the crystal structure of
the N-terminal 210 residues of RyR1 (RyR(NTD)) at 2.5 A. The RyR(NTD) structure
is similar to that of the suppressor domain of type 1 inositol
1,4,5-trisphosphate receptor (IP(3)Rsup), but lacks most of the long
helix-turn-helix segment of the "arm" domain in IP(3)Rsup. The N-terminal
beta-trefoil fold, found in both RyR and IP(3)R, is likely to play a critical
role in regulatory mechanisms in this channel family. A disease-associated
mutation "hot spot" loop was identified between strands 8 and 9 in a highly
basic region of RyR1. Biophysical studies showed that 3 MH-associated mutations
(C36R, R164C, and R178C) do not adversely affect the global stability or fold of
RyR(NTD), supporting previously described mechanisms whereby mutations perturb
protein-protein interactions.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
Features of the RyR[NTD] structure. (A) Ribbon diagram of
rabbit RyR[NTD]. The β-trefoil structure is separated into
barrel (blue strands) and cap (green strands). Dotted lines
represent missing residues. A top-down view is shown on the
right side. (B) Sequence alignment of the distal N-terminal
residues of RyR and IP[3]R isoforms. Residues highlighted in
teal, yellow, and magenta denote conservation in the different
layers of the barrel in both RyR[NTD] and IP[3]R[sup]. Residues
in red text correspond to mutations sites in RyR1 that lead to
MH or CCD, as well as to catecholaminergic polymorphic
ventricular tachycardia (CPVT) and arrhythmogenic right
ventricular dysplasia (ARVD2) for RyR2.
|
 |
Figure 2.
Comparison of RyR[NTD] and IP[3]R[sup] structures. (A)
Structural alignment of RyR[NTD] (purple) and IP[3]R[sup] (gray)
structures. Topology diagram for both structures are shown in B.
The 3-fold symmetry of the β-trefoil is evident, as well as
differences in the arm domain. The layering of residues in the
barrel is shown in C with the same color scheme as in Fig. 1B.
Electrostatic surface representation is represented for
IP[3]R[sup] and RyR[NTD] in D. A positive patch where mutations
cluster is outlined in yellow. Residues with basic side groups
found within and around the HS-loop are labeled. The structure
is oriented in the top-down view described in Fig. 1A.
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.W.Song,
J.G.Lee,
H.S.Youn,
S.H.Eom,
and
d.o. .H.Kim
(2011).
Ryanodine receptor assembly: a novel systems biology approach to 3D mapping.
|
| |
Prog Biophys Mol Biol, 105,
145-161.
|
 |
|
|
|
|
 |
C.C.Tung,
P.A.Lobo,
L.Kimlicka,
and
F.Van Petegem
(2010).
The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule.
|
| |
Nature, 468,
585-588.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.Wolfram,
E.Morris,
and
C.W.Taylor
(2010).
Three-dimensional structure of recombinant type 1 inositol 1,4,5-trisphosphate receptor.
|
| |
Biochem J, 428,
483-489.
|
 |
|
|
|
|
 |
M.J.Betzenhauser,
and
A.R.Marks
(2010).
Ryanodine receptor channelopathies.
|
| |
Pflugers Arch, 460,
467-480.
|
 |
|
|
|
|
 |
V.Bauerová-Hlinková,
E.Hostinová,
J.Gasperík,
K.Beck,
L.Borko,
F.A.Lai,
A.Zahradníková,
and
J.Sevcík
(2010).
Bioinformatic mapping and production of recombinant N-terminal domains of human cardiac ryanodine receptor 2.
|
| |
Protein Expr Purif, 71,
33-41.
|
 |
|
|
|
|
 |
C.W.Taylor,
D.L.Prole,
and
T.Rahman
(2009).
Ca(2+) channels on the move.
|
| |
Biochemistry, 48,
12062-12080.
|
 |
|
|
|
|
 |
P.A.Lobo,
and
F.Van Petegem
(2009).
Crystal structures of the N-terminal domains of cardiac and skeletal muscle ryanodine receptors: insights into disease mutations.
|
| |
Structure, 17,
1505-1514.
|
 |
|
PDB codes:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
| |